...acute myelogenous leukemia (AML) Cell culture and mouse studies suggest inhibiting GSK3A could help treat asparaginase-resistant... ...with asparaginase, co-treatment with two shRNAs against GSK3A or a tool compound GSK3A inhibitor increased asparaginase-induced... ...four T cell ALL, one B cell ALL and three AML cell lines treated with asparaginase...
...ALL treatment options as the reason for stopping the ALL program of Graspa, which comprises L-asparaginase... ...FDA and EMA provided feedback suggesting there would be "little room left" for a new asparaginase... ...Pharma S.A. (Euronext:ERYP; NASDAQ:ERYP), Lyon, France Product: Graspa eryaspase Business: Cancer Molecular target: NA Description: L-asparaginase...
...ALL treatment options as the reason for stopping the ALL program of Graspa, which comprises L-asparaginase... ...FDA and EMA provided feedback suggesting there would be "little room left" for a new asparaginase...